FOR IMMEDIATE RELEASE

New data from Portfolio shows sales of antimicrobial treatments as a percentage of F&I product sales increased as more Americans sought protection from communicable diseases.

LAKE FOREST, Calif. — Antimicrobial treatments gained ground as a percentage of all F&I product sales in March and April, reflecting renewed interest in eliminating and protecting against disease-causing pathogens among dealers, agents and consumers, according to internal data from Portfolio, a national provider and administrator of F&I products and dealer participation programs.